PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26314862-0	2015	Toward an understanding of the role of a catechol moiety in cancer chemoprevention: The case of copper- and o-quinone-dependent Nrf2 activation by a catechol-type resveratrol analog.	catechol	41-49	NFE2 like bZIP transcription factor 2	Homo sapiens	128-132	
28399452-4	2017	Mechanism studies indicate that its cytoprotective effects are mediated by activating the Nrf2 signaling pathway in the Michael acceptor- and catechol-dependent manners.	catechol	142-150	NFE2 like bZIP transcription factor 2	Homo sapiens	90-94	
26314862-0	2015	Toward an understanding of the role of a catechol moiety in cancer chemoprevention: The case of copper- and o-quinone-dependent Nrf2 activation by a catechol-type resveratrol analog.	catechol	149-157	NFE2 like bZIP transcription factor 2	Homo sapiens	128-132	
20558128-10	2010	We hypothesize that an electrophilic quinone formed as a consequence of oxidation of piceatannol bearing the catechol moiety may bind directly to Kelch-like ECH-associated protein 1 (Keap1), an inhibitory protein that sequesters Nrf2 in the cytoplasm.	catechol	109-117	NFE2 like bZIP transcription factor 2	Homo sapiens	229-233	
20558128-14	2010	The characteristic catechol moiety of piceatannol appears to be critical for induction of Nrf2 activation and subsequent upregulation of HO-1.	catechol	19-27	NFE2 like bZIP transcription factor 2	Homo sapiens	90-94	
19236154-4	2009	Two strategies are known to increase Nrf2 transcriptional activity in PD: i) use of certain catechol-derived quinones for selective inhibition of the Nrf2 repressor Kelch-like ECH-associated protein to increase of Nrf2 protein levels; and ii) use of glycogen synthase kinase 3beta inhibitors to maintain high protein and activity levels of Nrf2 in the nucleus.	catechol	92-100	NFE2 like bZIP transcription factor 2	Homo sapiens	37-41	
19236154-4	2009	Two strategies are known to increase Nrf2 transcriptional activity in PD: i) use of certain catechol-derived quinones for selective inhibition of the Nrf2 repressor Kelch-like ECH-associated protein to increase of Nrf2 protein levels; and ii) use of glycogen synthase kinase 3beta inhibitors to maintain high protein and activity levels of Nrf2 in the nucleus.	catechol	92-100	NFE2 like bZIP transcription factor 2	Homo sapiens	150-154	
19236154-4	2009	Two strategies are known to increase Nrf2 transcriptional activity in PD: i) use of certain catechol-derived quinones for selective inhibition of the Nrf2 repressor Kelch-like ECH-associated protein to increase of Nrf2 protein levels; and ii) use of glycogen synthase kinase 3beta inhibitors to maintain high protein and activity levels of Nrf2 in the nucleus.	catechol	92-100	NFE2 like bZIP transcription factor 2	Homo sapiens	150-154	
19236154-4	2009	Two strategies are known to increase Nrf2 transcriptional activity in PD: i) use of certain catechol-derived quinones for selective inhibition of the Nrf2 repressor Kelch-like ECH-associated protein to increase of Nrf2 protein levels; and ii) use of glycogen synthase kinase 3beta inhibitors to maintain high protein and activity levels of Nrf2 in the nucleus.	catechol	92-100	NFE2 like bZIP transcription factor 2	Homo sapiens	150-154	
14522084-0	2003	Nrf2, not the estrogen receptor, mediates catechol estrogen-induced activation of the antioxidant responsive element.	catechol	42-50	NFE2 like bZIP transcription factor 2	Homo sapiens	0-4